Literature DB >> 24052640

Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.

Thierry van den Bosch1, Anna E Koopmans, Jolanda Vaarwater, Mike van den Berg, Annelies de Klein, Robert M Verdijk.   

Abstract

PURPOSE: To examine the prognostic relevance of expression of the chemokine receptors CCR7 and CXCR4 and its ligand CXCL12 in uveal melanoma in nonmetastatic and metastatic patients with correlation to liver metastasis and overall survival.
METHODS: Primary uveal melanoma specimens from 19 patients with correlating liver metastasis specimens and 30 primary uveal melanoma specimens of patients without metastasis were collected between the years 1988 and 2008. Expression of CCR7, CXCR4, and CXCL12 were studied using immunohistochemistry. Single nucleotide polymorphism (SNP) arrays were used to examine gains or losses of chromosomes 1, 3, 6, and 8 and the regions of CCR7 (17q12-q21.2), CXCR4 (2q21), and CXCL12 (10q11.1) genes.
RESULTS: Strong cytoplasmic staining for CCR7 correlated with the presence of epithelioid cells (P = 0.037), tumor thickness (P = 0.011), lymphocytic infiltration (P = 0.041), and necrosis (P = 0.045). Nuclear staining for CXCR4 correlated with lymphocytic infiltration (P = 0.017). CXCL12 showed no correlation to histologic parameters. Single nucleotide polymorphism analyses showed no copy number variations in the regions of CCR7, CXCR4, or CXCL12. Strong expression of CCR7 was observed in 76% of the metastatic patients and 0% of nonmetastasis patients. In multivariate analysis, CCR7 staining was inversely correlated to overall survival and disease-free survival, whereas CXCR4 nuclear staining was not.
CONCLUSIONS: Our data suggest that CCR7 plays a role in uveal melanoma metastasis and is associated with poor survival. CCR7 and its involved related pathways are of prognostic value in uveal melanoma and may prove to be a target for therapeutic intervention.

Entities:  

Keywords:  SNP analyses; chemokine receptors; survival analyses; uveal melanoma

Mesh:

Substances:

Year:  2013        PMID: 24052640     DOI: 10.1167/iovs.13-12407

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  16 in total

1.  Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.

Authors:  Lei Dong; Shuo You; Qing Zhang; Satoru Osuka; Narra S Devi; Stefan Kaluz; Jalisa H Ferguson; Hua Yang; Guoliang Chen; Binghe Wang; Hans E Grossniklaus; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2018-12-18       Impact factor: 12.531

2.  CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.

Authors:  Yongqian Chen; Ye Tian; Zhengguo Ji; Zhi Liu; Donghao Shang
Journal:  Tumour Biol       Date:  2015-02-15

3.  Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck.

Authors:  Zhongti Zhang; Fayu Liu; Zhenning Li; Dan Wang; Ruiwu Li; Changfu Sun
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

4.  In vitro and in vivo studies on the inhibitory effects of myocardial cell culture medium on growth of a human lung adenocarcinoma cell line, A549.

Authors:  Y Zheng; J Zhou; S Z Fu; J Fan; J B Wu
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 5.  C-C Chemokine Receptor 7 in Cancer.

Authors:  Colin A Bill; Christopher M Allen; Charlotte M Vines
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

6.  Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.

Authors:  Austin J Barmore; Sally M Castex; Brittany A Gouletas; Alex J Griffith; Slater W Metz; Nicolas G Muelder; Michael J Populin; David M Sackett; Abigail M Schuster; Christopher T Veldkamp
Journal:  Biochem Biophys Res Commun       Date:  2016-06-21       Impact factor: 3.575

7.  Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.

Authors:  Edward W Roberts; Miranda L Broz; Mikhail Binnewies; Mark B Headley; Amanda E Nelson; Denise M Wolf; Tsuneyasu Kaisho; Dusan Bogunovic; Nina Bhardwaj; Matthew F Krummel
Journal:  Cancer Cell       Date:  2016-07-14       Impact factor: 31.743

8.  The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration.

Authors:  Jianjun Bi; Peng Li; Chuanyin Li; Jie He; Ying Wang; He Zhang; Xianqun Fan; Renbing Jia; Shengfang Ge
Journal:  Tumour Biol       Date:  2015-10-22

Review 9.  The role of chemoattractant receptors in shaping the tumor microenvironment.

Authors:  Jiamin Zhou; Yi Xiang; Teizo Yoshimura; Keqiang Chen; Wanghua Gong; Jian Huang; Ye Zhou; Xiaohong Yao; Xiuwu Bian; Ji Ming Wang
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

10.  CCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck.

Authors:  Fa-Yu Liu; Jawad Safdar; Zhen-Ning Li; Qi-Gen Fang; Xu Zhang; Zhong-Fei Xu; Chang-Fu Sun
Journal:  Biomed Res Int       Date:  2014-10-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.